Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja CSIS WARRANT SERIES I (CSIS-W) vs UBC Medical Indonesia Tbk. (LABS)

CSIS WARRANT SERIES ITrading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan CSIS WARRANT SERIES I dan UBC Medical Indonesia Tbk.: CSIS WARRANT SERIES I diperdagangkan di Rp88 (kapitalisasi pasar 4,18 M, volume 24 jam 74,2 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 152,1× kapitalisasi pasar CSIS WARRANT SERIES I, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (843 rb vs 74,2 rb). Mana yang lebih baik tergantung tujuan investasimu.

CSIS-WLABS
Kapitalisasi Pasar
4,18 M635,95 M
Volume
74,2 rb843 rb
Lot
7428,43 rb
Perputaran
5,69 jt137,6 jt
Harga Rata-rata
76,65163,22
Nilai Transaksi
5,69 jt137,6 jt
Harga Ekuilibrium Indikatif
88165
Volume Ekuilibrium Indikatif
1246

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail

Tentang CSIS WARRANT SERIES I

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Selengkapnya di halaman CSIS-W

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS